Alzamend Neuro Files 8-K for Material Agreements

TL;DR

Alzamend Neuro (ALZN) filed an 8-K detailing material agreements and changes to security holder rights.

AI Summary

Alzamend Neuro, Inc. announced on March 22, 2024, that it entered into a Material Definitive Agreement. The company also made material modifications to the rights of its security holders and amended its articles of incorporation or bylaws. The filing includes financial statements and exhibits related to these events.

Why It Matters

This 8-K filing indicates significant corporate actions by Alzamend Neuro, including new agreements and changes affecting security holders, which could impact the company's strategic direction and shareholder value.

Risk Assessment

Risk Level: medium — Material definitive agreements and modifications to security holder rights can introduce significant changes and potential risks to a company's operations and financial standing.

Key Players & Entities

• Alzamend Neuro, Inc. (company) — Registrant
• March 22, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value ALZN The Nasdaq Capital M

Filing Documents

• o3222418k.htm (8-K) — 29KB
• ex3_1.htm (EX-3.1) — 2KB
• ex4_1.htm (EX-4.1) — 12KB
• ex31-001.jpg (GRAPHIC) — 50KB
• ex31-002.jpg (GRAPHIC) — 130KB
• 0001214659-24-005032.txt ( ) — 471KB
• alzn-20240322.xsd (EX-101.SCH) — 3KB
• alzn-20240322_lab.xml (EX-101.LAB) — 33KB
• alzn-20240322_pre.xml (EX-101.PRE) — 22KB
• o3222418k_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On March 21, 2024, Alzamend Neuro, Inc., a Delaware corporation (the " Company ") entered into a warrant amendment agreement (the " Warrant Amendment Agreement ") with Ault Lending, LLC, a California limited liability company (the " Holder ") , relating to the warrant issued to the Holder on January 31, 2024 (the " Warrant "), pursuant to a s ecurities purchase agreement between the Company and the Holder, whereby the Holder purchased shares of Series B convertible preferred stock (" Series B Convertible Preferred Stock ") and the Warrant. Pursuant to the Warrant Amendment Agreement, the Holder agreed to amend the Warrant to revise section 3(d) to remove certain language that could have caused the Warrant to not be classified as equity. No other amendments were made to the Warrant. The forgoing description of the Company's Warrant Amendment Agreement is qualified in its entirety by reference to the full text of such document, a copy of which is filed as Exhibit 4.1 to this Current Report on Form 8-K.

03 Material Modification to Rights of Security Holders

Item 3.03 Material Modification to Rights of Security Holders. The disclosure set forth in Item 5.03 below is hereby incorporated herein by reference.

03 Amendments to Articles of Incorporation or Bylaws; Change In Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change In Fiscal Year. As previously reported on Current Report Form 8-K filed on March 6, 2024, on March 1, 2024, the Company filed an Amended and Restated Certificate of Designations of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (the " First Amended and Restated Certificate of Designations "). On March 21, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the First Amended and Restated Certificate of Designations (the " COD Amendment "). The COD Amendment amended the First Amended and Restated Certificate of Designations to delete sections 5(b) and 5(c) to remove certain language regarding liquidation preference rights that could have caused the Series B Convertible Preferred Stock to not be classified as equity. No other amendments were made to the First Amended and Restated Certificate of Designations. The foregoing description of the COD Amendment is qualified in its entirety by reference to the full text of such document, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Designations of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, filed with the Delaware Secretary of State on March 21, 2024. 4.1 Form of Amendment to Warrant. 101 Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101). -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALZAMEND NEURO, INC. Dated: March 22, 2024 /s/ Henry Nisser Henry Nisser Executive Vice President and General Counsel -3-

View Full Filing

View this 8-K filing on SEC EDGAR